May 24, 2021 / 05:00PM GMT
Operator
Thank you for standing by, and welcome to the Fluidigm mass cytometry investor event. (Operator Instructions) As a reminder, today's conference call is being recorded.
I would now like to turn the conference over to your host, Mr. Peter DeNardo. Sir, you may begin.
Peter Denardo -
Thank you, Valerie, and hello, everyone, and apologies for our delayed start time due to some technical problems we experienced in connecting. Welcome to Fluidigm's first-ever investor event today focused on the company's mass cytometry business. During this call, we will review this part of our business, provide commentary on our financial and operational performance, market trends, strategic initiatives as well as discuss our product innovation and strategic growth plans.
Presenting for Fluidigm today will be Chris Linthwaite, our President and CEO; and Steve Kulisch, Senior Vice President, General Manager and Head of Strategic Marketing. We are also pleased to have joining us today a couple of key customers. These include Nasry Yassa and Andrew Brown of Sirona Dx; and
Fluidigm Corp Virtual Mass Cytometry Investor Day Transcript
May 24, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers